KEDNA ROBERT: Open Payments
NPI 1790213148 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 29 payments from 17 companies in 2025. Trend: 2023 $791 · 2024 $743 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 5 | $203 |
| Novo Nordisk Inc | 2 | $142 |
| Medtronic, Inc. | 1 | $132 |
| PFIZER INC. | 3 | $79 |
| Novartis Pharmaceuticals Corporation | 2 | $59 |
| Merck Sharp & Dohme LLC | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| ABIOMED | 2 | $40 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
Products named: Barostim Neo System, Ozempic, SYMPLICITY G3, ELIQUIS, LEQVIO, VERQUVO, VYNDAQEL, UPTRAVI.
Industry payments across FL — which companies pay providers there.
